Intra-Cellular Therapies (ITCI), down 1.73% after filing to sell $300M of common stock...
AMBA had terrible earnings so folks were on the same page, FIT had over the top earnings, stupid to compare AMBA with bad earnings and FIT with hitting it out of the ballpark earnings.
Thanks : )
thats a fact
good link - folks just want your shares cheap before bounce back which technical s are showing.